More recently, our study demonstrated that the synthetic curcumin derivative HBC, a Ca2+/CaM antagonist, inhibits the stem-like features of GBM cells by downregulating the CaM/CaMKIIγ/c-Met pathway [25]. The gene discussed is MET; the disease is glioblastoma.